TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IMCR

Immunocore Holdings Ltd

Healthcare · Biotechnology

30.60$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Immunocore Holdings Ltd (IMCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 298 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IMCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
6.4 11 16 14 24 26 30 27 144 197 248 298
– – – – – 100 75 74 5.3 0.8 5.5 6.2
6.4 11 16 14 24 -74 -45 27 139 197 242 291
12 22 46 61 84 100 75 74 84 129 177 204
2.5 3.0 3.7 22 34 44 46 119 94 155 156 165
14 25 49 83 118 44 41 156 182 244 299 325
-7.3 -14 -32 -68 -93 -118 -86 -129 -43 -47 -56 -34
– – 0.0 0.0 0.8 3.8 3.1 5.6 5.4 4.1 19 12
-7.2 14 -31 -65 -88 -82 -87 -133 -34 -48 -42 -14
1.6 1.0 8.1 16 -17 22 -13 0.1 9.6 -4.4 -1.5 12
-5.6 13 -23 -50 -72 -104 -74 -133 -43 -44 -41 -26
-6.6 -11 -30 -64 -87 -112 -82 -124 -38 -41 -39 0.4

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?